Comparison of ketorolac tromethamine and prednisolone acetate in preventing surgically induced miosis during cataract surgery

Sultan Qaboos University Medical Journal

Volumn 10, Issue 1, 2010, Pages 57-63

  Suleiman, Yusuf M ^a   Krdoghli, Najwa F ^a   Ahmad, Aksam J ^a  

^a TISHREEN UNIVERSITY   (Syrian Arab Republic)

Author keywords

Cataract extraction; Ketorolac tromethamine; Miosis; Mydriasis; Prednisolone acetate

Indexed keywords

EID: 84861160731     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Colin J. The Role of NSAIDs in the Management of postoperative ophthalmic Inflammation. Drugs 2007; 67:1291–308.
2. Moorthy RS, Davis J, Foster CS, Lowder CY, Vitale AT, Lopatynsky M, et al. Intraocular inflammation and uveitis. In: American Academy of Ophthalmology. Basic and Clinical Science Course, 2007-2008. Singapore: AAO, 2007. pp.77–9.
3. Koay P. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol 1996; 80:480–5.
4. Drolsum L, Davanger M, Haaskjold E. Risk factors for an inflammatory response after extracapsular cataract extraction and posterior chamber IOL. Acta Ophthalmol (Copenh) 1994; 72:21–6.
5. Goodman DF, Stark WJ, Gottsch JD. Complication of cataract extraction with intraocular lens implantation. Ophthalmic Surg 1989; 20:132–40.
6. Cillino S, Casanova F, Cucco F, Ponte F. Topical flurbiprofen in extracapsular cataract surgery: Effect on pupillary diameter and iris fluorescein leakage. J Cataract Refract Surg 1993; 19:622–5.
7. Stark WJ, Fagadu WR, Stewart RH. Reduction of pupillary constriction during cataract surgery using suprofen. Arch Ophthalmol 1986; 104:364–6.
8. Demco TA, Sutton H, Demco CJ, Raj PS. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification–lens implant surgery. Eur J Ophthalmol 1997; 7:236–40.
9. Solomon KD, Vroman DT, Barker D. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. J Cataract Refract Surg 2001; 27:1232–7.
10. Sivaprasad S, Bunce C, Wormald R. Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: A systematic Review. Br J Ophthalmol 2005; 89:1420–2.
11. Gwon A, Vaughan ER, Cheetham JK, DeGryse R. Ocufen (Flurbiprofen) in the treatment of ocular pain after radial keratotomy. CLAO J 1994; 20:131–8.
12. Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ. Topical 0.5% Ketorolac vs 0.03% Flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol 1997; 115:1119–22.
13. Epstein RL, Laurence EP. Relative effectiveness of topical ketorolac and topical diclofenac on discomfort after radial keratotomy. J Cataract Refract Surg 1995; 21:156–9.
14. Flach AJ, Jampol LM, Weinberg D, Kraff MC, Yannuzzi LA, Campo RV et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991; 112:514–9.
15. Flach AJ, Graham J, Kruger LP, Stegman RC, Tanenbaum L. Quantitative assessment of postsurgical breakdown of the blood aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison vehicle placebo solution study. Arch Ophthalmol 1988; 106:344–7.
16. Bron A, Denis P, Hoang-Xuan TC, Boureau-Andrieux C, Crozafon P, Hachet E, et al. The effects of rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. Eur J Ophthalmol 1998; 8:16–21.
17. Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial. Am J Ophthalmol 1999; 127:253–9.
18. Stewart R, Grosserode R, Cheetham J K, Rosenthal A. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 1999; 21:723–32.
19. Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. J Cataract Refract Surg 2000; 26:1225–7.
20. Ostrov CS, Sirkin SR, Deutsch WE, Masi RJ, Chandler JW, Lindquist TD. Ketorolac, prednisolone, and dexamethasone for postoperative inflammation. Clin Ther 1997; 9:259–72.
21. Hirneiß C, Neubauer AS, Kampik A, Schönfeld C. Comparison of prednisolone 1%, rimexolone1% and ketorolac tromethamine 0.5% after cataract extraction. Graefes Arch Clin Exp Ophthalmol 2005; 243:768–73.
22. Simone JM, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999; 25:699–704.
23. El-Harazi SM, Ruis RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 1998; 29:539–44.
24. Donald RS, Manus CK, Howard LL, Gholam AP, Samih T. Breakdown and reestablishment of blood-aqueous barrier with implant surgery. Arch Ophthalmol 1982; 100:588–90.
25. Donald RS, Manus K. Steroidal and nonsteroidal anti-inflammatory agents: effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol 1984; 102:1453–6.
26. Donald RS, Alan S, Colman K, Parashos L, Bruce G, Gholam AP. Quantitative assessment of postsurgical breakdown of the blood-aqueous arrier. Arch Ophthalmol 1983; 101:131–3.
27. Mackool RJ, Muldoon T, Fortier A, Nelson D. Epinephrine-induced cystoid macular edema in aphakic eyes. Arch Ophthalmol 1977; 95:791–3.
28. Obstbaum SA, Galin MA, Poole TA. Topical epinephrine and cystoid macular edema. Am J Ophthalmol 1976; 8:455–8.